These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1713996)

  • 1. Effects of calcium channel blockers on stress protein synthesis in cardiac myocytes.
    Löw-Friedrich I; Schoeppe W
    J Cardiovasc Pharmacol; 1991 May; 17(5):800-6. PubMed ID: 1713996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Stress proteins" as a cellular endpoint to detect cardiotoxicity in vitro.
    Löw-Friedrich I; Schoeppe W
    ALTEX; 1991; 8(2):5-16. PubMed ID: 11178559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated rat cardiac myocytes as an experimental model to study calcium overload: the effect of calcium-entry blockers.
    Donck LV; Pauwels PJ; Vandeplassche G; Borgers M
    Life Sci; 1986 Mar; 38(9):765-72. PubMed ID: 3951332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells.
    Barry WH; Horowitz JD; Smith TW
    Br J Pharmacol; 1985 May; 85(1):51-9. PubMed ID: 4027472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of organic calcium-channel blockers on diastolic SR calcium-handling in the frog heart.
    Subramani S; Vijayanand C; Tharion E
    Br J Pharmacol; 2002 Nov; 137(6):756-60. PubMed ID: 12411405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
    Sato R; Yamazaki J; Nagao T
    J Pharmacol Exp Ther; 1999 May; 289(2):831-9. PubMed ID: 10215660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature dependence of calcium antagonist action.
    Piper HM; Hütter JF; Spieckermann PG
    Arzneimittelforschung; 1985; 35(10):1495-8. PubMed ID: 4074403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared.
    Nakaya H; Schwartz A; Millard RW
    Circ Res; 1983 Mar; 52(3):302-11. PubMed ID: 6825222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1982 Jul; 81(3):403-9. PubMed ID: 6981516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myocardial cellular mechanism of action of calcium antagonists].
    Ferrari R; Boffa GM; Ciampalini G; Ceconi C
    Cardiologia; 1985 Feb; 30(2):77-89. PubMed ID: 3905004
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential potentiation by depolarization of the effects of calcium antagonists on contraction and Ca2+ current in guinea-pig heart.
    Okuyama R; Adachi-Akahane S; Nagao T
    Br J Pharmacol; 1994 Oct; 113(2):451-6. PubMed ID: 7834195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blocking drugs.
    Johnston WE; Lowenstein E
    Contemp Anesth Pract; 1983; 7():163-91. PubMed ID: 6309475
    [No Abstract]   [Full Text] [Related]  

  • 17. Different effects of calcium channel blockers on matrix metalloproteinase-2 expression in cultured rat cardiac fibroblasts.
    Yue H; Uzui H; Shimizu H; Nakano A; Mitsuke Y; Ueda T; Lee JD
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):223-30. PubMed ID: 15243304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium.
    Schwinger RH; Böhm M; Erdmann E
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):185S-187S. PubMed ID: 1827017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists stimulate prostaglandin synthesis by cultured rat cardiac myocytes and prevent the effects of hypoxia.
    Escoubet B; Griffaton G; Samuel JL; Lechat P
    Biochem Pharmacol; 1986 Dec; 35(24):4401-7. PubMed ID: 3539119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
    Soward AL; Vanhaleweyk GL; Serruys PW
    Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.